Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217332 · ClinicalTrials.gov registry record · Phase 2
Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia
A Phase 2 study, sponsored by Knopp Biosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02217332 is a Phase 2 study that has completed, run by Knopp Biosciences. The registered enrollment target is 20 participants.
The verdict
NCT02217332, a Phase 2 study, has completed, sponsored by Knopp Biosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
Interventions
- DRUG dexpramipexole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-01-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02217332
The ClinicalTrials.gov registry entry for NCT02217332 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Knopp Biosciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which dexpramipexole is the first listed.
NCT02217332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02217332 about?
NCT02217332 is a clinical study titled "Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and Eosinophilia". Phase 2, open-label, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 6 months in subjects with chronic sinusitis with nasal polyps and eosinophilia.
What is the current status of trial NCT02217332?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-08. Estimated completion is 2017-01-20.
What interventions are being tested in trial NCT02217332?
The interventions under investigation include: dexpramipexole (DRUG).
Who is sponsoring clinical trial NCT02217332?
This trial is sponsored by Knopp Biosciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.